Owns and leases skilled nursing facilities. Acquires seniors housing properties. Now — the numbers.
This is an established company with proven profits.
Average growth of 26% a year over the last 4 years. Red columns mark years that ended in a loss.
The gap is $696.2M. In times of high interest rates, a gap like that can squeeze a company.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit power and business quality lead the class.
A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.
Clearly below the class average.
Sales are growing strongly for its sector.
Clearly above the class average — a step short of the very top.
Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.
The stock trades below its recent peak — about 11% off the top. A pullback, not a collapse.
The net profit margin is 67% — still a thick cushion, though costs have been eating into it lately.
Over the last 4 years, sales grew about 26% a year on average.
Over the last 12 months, company executives reported 13 buys and 5 sells. Management buying with its own money is usually read as a good sign.
Today’s price already includes part of tomorrow’s optimism. Report-card grade: 37/100.
On our five-subject report card, CTRE sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”
The takeaway: CTRE is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.
Analysts’ average target sits above today’s price, yet the valuation grade (37/100) says the stock isn’t cheap.
Not covered, because the filings we hold do not carry it: the revenue breakdown.